Communiqués Correvio Pharma Corp.

Actions

CORV

CA22026V1058

Temps Différé Toronto S.E. Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^CAD	-.--%		-5,08 %	+3,70 %

2020	Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call
2019	Transcript : Correvio Pharma Corp., Q3 2019 Earnings Call, Nov 14, 2019

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Correvio Pharma : Obtains Final Order for Plan of Arrangement	21/05/20	PR
Correvio Pharma : Announces Results from Annual General and Special Meeting of Securityholders	15/05/20	PR
Correvio Pharma : Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA	06/05/20	PR
Correvio Pharma : Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	04/05/20	PR
Correvio Pharma : Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	01/05/20	PR
Correvio Pharma : Obtains Interim Order For Plan Of Arrangement	08/04/20	PR
Correvio Pharma : Reports Full Year 2019 Financial Results	30/03/20	PR
CORREVIO PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Correvio Pharma Corp. - CORV	21/03/20	BU
Correvio Pharma : ADVANZ PHARMA to Acquire Correvio	16/03/20	PR
Correvio Pharma : Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities	28/01/20	PR
Correvio Pharma : Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events	24/12/19	PR
Correvio Pharma : IIROC Trade Resumption - CORV	11/12/19	AQ
Correvio Pharma : IIROC Trading Halt - CORV	10/12/19	AQ
Correvio Pharma : to Present at the 2019 Cantor Global Healthcare Conference	27/09/19	PR
Correvio Pharma : to Present at the H.C. Wainwright 21st Annual Global Investment Conference	04/09/19	PR
Correvio Pharma : Closes Public Offering of 9,200,000 Common Shares	07/08/19	PR
Correvio Pharma : Announces Pricing Of Public Offering Of Common Shares	02/08/19	PR
Correvio Pharma : Announces Overnight Marketed Offering of Common Shares	01/08/19	PR
Correvio Pharma : to Report First Quarter 2019 Financial Results on May 8, 2019	01/05/19	PR
Correvio Pharma : to present at the H.C. Wainwright Global Life Sciences Conference	02/04/19	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Correvio Pharma Corp.

Actions

CORV

CA22026V1058

Communiqués

Filtres